PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
18 hedge funds and large institutions have $13.9M invested in PLx Pharma Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
23% more capital invested
Capital invested by funds: $11.3M → $13.9M (+$2.61M)
6% more funds holding
Funds holding: 17 → 18 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
Nottingham Advisors
Amherst,
New York
|
+$318K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$178K |
| 3 |
Renaissance Technologies
New York
|
+$33.1K |
| 4 |
BlackRock
New York
|
+$32.2K |
| 5 |
AG
Aperio Group
Sausalito,
California
|
+$10K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$1.31M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$392K |
| 3 |
Millennium Management
New York
|
-$12.8K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$11K |
PLXP Hedge Fund Activity: Q2 2019 in Review
18 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2019, worth a combined $13.9M — up 23% from $11.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PLXP positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Nottingham Advisors, opening a new position worth an estimated $318K. The largest seller was Harel Insurance Investments & Financial Services, exiting entirely with an estimated $1.31M sold.
- 18 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2019, up from 17 in Q1 2019.
- Funds reported $13.9M of PLx Pharma Inc. Common Stock stock for Q2 2019, up 23% quarter-over-quarter.
- 4 funds opened new PLx Pharma Inc. Common Stock positions in Q2 2019 and 3 closed out, a net change of +1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2019 was Nottingham Advisors, an estimated $318K added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2019 was Harel Insurance Investments & Financial Services, an estimated $1.31M sold.
Based on aggregated 13F filings for Q2 2019.